INFLUENCE OF DRUG LEVELS DURING THE FIRST ANTI-TNF THERAPY ON THE CLINICAL RESPONSE TO A SECOND BIOLOGIC IN RHEUMATOID ARTHRITIS PATIENTS

被引：0
|
作者：
Plasencia-Rodriguez, C. [1 ]
Pascual-Salcedo, M. D. [2 ]
Bonilla, G. [1 ]
Navarro-Compan, V. [1 ]
Martinez-Feito, A. [2 ]
Diego, C. [2 ]
Villalba, A. [1 ]
Peiteado, D. [1 ]
Nuno, L. [1 ]
Martin-Mola, E. [1 ]
Balsa, A. [1 ]
机构：
[1] La Paz Univ Hosp Idipaz, Rheumatol, Madrid, Spain
[2] La Paz Univ Hosp Idipaz, Immunol, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5036
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0305
引用
收藏
页码：1004 / 1004
页数：1
相关论文
共 50 条
  • [1] Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug A Randomized Clinical Trial
    Gottenberg, Jacques-Eric
    Brocq, Olivier
    Perdriger, Aleth
    Lassoued, Slim
    Berthelot, Jean-Marie
    Wendling, Daniel
    Euller-Ziegler, Liana
    Soubrier, Martin
    Richez, Christophe
    Fautrel, Bruno
    Constantin, Arnaud L.
    Mariette, Xavier
    Morel, Jacques
    Gilson, Melanie
    Cormier, Gregoire
    Salmon, Jean Hugues
    Rist, Stephanie
    Liote, Frederic
    Marotte, Hubert
    Bonnet, Christine
    Marcelli, Christian
    Sellam, Jeremie
    Meyer, Olivier
    Solau-Gervais, Elisabeth
    Guis, Sandrine
    Ziza, Jean-Marc
    Zarnitsky, Charles
    Chary-Valckenaere, Isabelle
    Vittecoq, Olivier
    Saraux, Alain
    Pers, Yves-Marie
    Gayraud, Martine
    Bolla, Gilles
    Claudepierre, Pascal
    Ardizzone, Marc
    Dernis, Emmanuelle
    Breban, Maxime A.
    Fain, Olivier
    Balblanc, Jean-Charles
    Aberkane, Ouafaa
    Vazel, Marion
    Back, Christelle
    Candon, Sophie
    Chatenoud, Lucienne
    Perrodeau, Elodie
    Sibilia, Jean
    Ravaud, Philippe
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (11): : 1172 - 1180
  • [2] Drug Survival of Second Biologic DMARD Therapy in Patients with Rheumatoid Arthritis: Comparison of a Second Anti-TNF with a Second Non-Anti-TNF after Discontinuation of a First Anti-TNF
    Wilke, T.
    Mueller, S.
    Majer, I.
    Heisen, M.
    Fuchs, A.
    Maywald, U.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [3] Choice of second biologic in rheumatoid arthritis patients with inadequate response to initial anti-TNF
    Gandiga, P. C.
    George, M. D.
    Baker, J. F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (02) : S19 - S19
  • [4] Influence of Immunogenicity to the First Anti-TNF Therapy on Response to the Second Biologic Agent in RA Patients
    Bogas, Patricia
    Plasencia-Rodriguez, Chamaida
    Balsa, Alejandro
    Pascual-Salcedo, Dora
    Bonilla, Gema
    Moral Coro, Enrique
    Tornero, Carolina
    Nuno, Laura
    Peiteado, Diana
    Martinez, Ana
    Hernandez, Borja
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [5] High Levels Of Memory B CELLS ARE Associated With Response To A First ANTI-TNF Drug In Patients With Rheumatoid Arthritis
    Daien, Claire I.
    Gailhac, Sarah
    Mura, Thibault
    Combe, Bernard
    Hahne, Michael
    Morel, Jacques
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S195 - S195
  • [6] ASSOCIATION OF THE MICA POLYMORPHISM WITH CLINICAL RESPONSE TO ANTI-TNF THERAPY IN RHEUMATOID ARTHRITIS PATIENTS
    Iwaszko, Milena
    Swierkot, Jerzy
    Kolossa, Katarzyna
    Jeka, Slawomir
    Wiland, Piotr
    Bogunia-Kubik, Katarzyna
    HLA, 2017, 89 (06) : 466 - 466
  • [7] The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug
    Soderlin, M. K.
    Petersson, I. F.
    Geborek, P.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2012, 41 (01) : 1 - 9
  • [8] Effect of switching to a second anti-TNF therapy on HAQ response in rheumatoid arthritis patients with lack of response to their first anti-TNF therapy: Results from the BSR biologics register (BSRBR)
    Hyrich, K. L.
    Lunt, M.
    Watson, K. D.
    Dixon, W. G.
    Symmons, D. P. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 173 - 173
  • [9] Benefit of switching to a second anti-TNF therapy on HAQ response in rheumatoid arthritis patients with lack of response to their first anti-TNF therapy: Results from the BSR biologics register (BSRBR)
    Lunt, M.
    Hyrich, K. L.
    Watson, K. D.
    Dixon, W. G.
    Symmons, D. P.
    RHEUMATOLOGY, 2007, 46 : I16 - I16
  • [10] Predicting response to anti-TNFα therapy among patients with rheumatoid arthritis
    Hyrich, K
    Watson, K
    Symmons, D
    Silman, A
    RHEUMATOLOGY, 2005, 44 : I24 - I24
12345